January 12, 2010
FDA Warns Lilly Over False, Misleading Cymbalta Ads
The FDA has issued a warning to Eli Lilly concerning print ads for its anti-depressant Cymbalta. I've not been able to find the letter but have seen multiple press accounts. Here's what the FDA apparently said.
"'The print ad is false or misleading in that it presents efficacy claims for Cymbalta, but fails to adequately communicate the risks associated with its use,' the FDA said. 'The Blue Book Message is false or misleading because it overstates the efficacy of Cymbalta and minimizes the risks associated with the drug.'"
Risks associated with an anti-depressant? A pharma company downplaying risks? I've never heard of such a thing!
Posted by Philip Dawdy at January 12, 2010 03:06 PM
del.icio.us
Digg it
reddit
Dear Lord!
Breaking news at Furious Seasons!
Me too I never heard any of these problems and... is it FDA that is warning Eli-Lilly?
The same FDA that claimed it was against the law "revealing trade secrets" during investigations of Traci Johnson suicidal Eli-Lily's facilities during Cymbalta clinical trial?
What a shock!
You know it's interesting...got an invitation to attend a psychiatrist led info session on bipolar depression at a swanky suburban steakhouse. I knew better than to take it at face value, so I perused the invite and sure enough there was AstraZeneca's logo at the bottom. Can you say "Seroquel?" Been seeing so many TV ads as of late. Gotta' combat Abilify and Bristol-Myers Squibb. The great atypical wars!
